Article, 2024

Semaglutide and Cardiovascular Outcomes. Reply.

New England Journal of Medicine, ISSN 1533-4406, 0028-4793, Volume 390, 8, Pages 768-769, 10.1056/nejmc2400414

Contributors

Lincoff, A Michael [1] Ryan, Donna Harrington 0000-0001-8374-2277 [2] Esbjerg, Sille [3]

Affiliations

  1. [1] Cleveland Clinic
    2. [NORA names: United States; America, North; OECD];
  2. [2] Pennington Biomedical Research Center
    3. [NORA names: United States; America, North; OECD];
  3. [3] Novo Nordisk (Denmark)
    4. [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD]

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+